GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » Total Liabilities

Haleon (LSE:HLN) Total Liabilities : £18,091 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Total Liabilities?

Haleon's Total Liabilities for the quarter that ended in Dec. 2024 was £18,091 Mil.

Haleon's quarterly Total Liabilities declined from Jun. 2024 (£16,689.00 Mil) to Sep. 2024 (£0.00 Mil) but then increased from Sep. 2024 (£0.00 Mil) to Dec. 2024 (£18,091.00 Mil).

Haleon's annual Total Liabilities declined from Dec. 2022 (£18,358.00 Mil) to Dec. 2023 (£17,326.00 Mil) but then increased from Dec. 2023 (£17,326.00 Mil) to Dec. 2024 (£18,091.00 Mil).


Haleon Total Liabilities Historical Data

The historical data trend for Haleon's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Total Liabilities Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial 7,907.00 7,971.00 18,358.00 17,326.00 18,091.00

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,326.00 - 16,689.00 - 18,091.00

Haleon Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Haleon's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5812+(8615+3533
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+131+0)
=18,091

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=34315-16224
=18,091

Haleon's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5812+(8615+3533
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+131+0)
=18,091

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=34315-16224
=18,091

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haleon Total Liabilities Related Terms

Thank you for viewing the detailed overview of Haleon's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Haleon Business Description

Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.